Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Diver

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
The Journal of Allergy and Clinical Immunology|May 10, 2022
Feno differentiates epithelial gene expression clusters: Exploratory analysis from the MESOS randomized controlled trialSarah Diver, Sriram Sridhar, Latifa C Khalfaoui, et al.
The Lancet. Respiratory Medicine|May 10, 2021
The inflammatory profile of exacerbations in patients with severe refractory eosinophilic asthma receiving mepolizumab (the MEX study): a prospective observational studyP Jane McDowell, Sarah Diver, Freda Yang, et al.
The Lancet. Respiratory Medicine|July 13, 2021
Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trialSarah Diver, Latifa Khalfaoui, Claire Emson, et al.
NEJM Evidence|February 6, 2024
Tezepelumab and Mucus Plugs in Patients with Moderate-to-Severe AsthmaLars H Nordenmark, Åsa Hellqvist, Claire Emson, et al.
Allergy|May 21, 2019
Mepolizumab does not alter the blood basophil count in severe asthmaAdam Kelvin Alec Wright, Sarah Diver, Jamie McCarthy, et al.
The Journal of Allergy and Clinical Immunology|July 1, 2025
Analysis of airway inflammation demonstrates a mechanism for T2-biologic failure in asthmaP Jane McDowell, Adnan Azim, John Busby, et al.
Allergy|September 27, 2019
Sputum microbiomic clustering in asthma and chronic obstructive pulmonary disease reveals a Haemophilus-predominant subgroupSarah Diver, Matt Richardson, Koirobi Haldar, et al.
The European Respiratory Journal|March 26, 2021
Multi-omics links IL-6 trans-signalling with neutrophil extracellular trap formation and <i>Haemophilus</i> infection in COPDSofia Winslow, Lina Odqvist, Sarah Diver, et al.
The Journal of Allergy and Clinical Immunology|May 1, 2018
Biological exacerbation clusters demonstrate asthma and chronic obstructive pulmonary disease overlap with distinct mediator and microbiome profilesMichael A Ghebre, Pee Hwee Pang, Sarah Diver, et al.
The European Respiratory Journal|August 31, 2019
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questionsArnaud Bourdin, Leif Bjermer, Christopher Brightling, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
The Journal of Allergy and Clinical Immunology|May 10, 2022
Feno differentiates epithelial gene expression clusters: Exploratory analysis from the MESOS randomized controlled trialSarah Diver, Sriram Sridhar, Latifa C Khalfaoui, et al.
The Lancet. Respiratory Medicine|May 10, 2021
The inflammatory profile of exacerbations in patients with severe refractory eosinophilic asthma receiving mepolizumab (the MEX study): a prospective observational studyP Jane McDowell, Sarah Diver, Freda Yang, et al.
The Lancet. Respiratory Medicine|July 13, 2021
Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trialSarah Diver, Latifa Khalfaoui, Claire Emson, et al.
NEJM Evidence|February 6, 2024
Tezepelumab and Mucus Plugs in Patients with Moderate-to-Severe AsthmaLars H Nordenmark, Åsa Hellqvist, Claire Emson, et al.
Allergy|May 21, 2019
Mepolizumab does not alter the blood basophil count in severe asthmaAdam Kelvin Alec Wright, Sarah Diver, Jamie McCarthy, et al.
The Journal of Allergy and Clinical Immunology|July 1, 2025
Analysis of airway inflammation demonstrates a mechanism for T2-biologic failure in asthmaP Jane McDowell, Adnan Azim, John Busby, et al.
Allergy|September 27, 2019
Sputum microbiomic clustering in asthma and chronic obstructive pulmonary disease reveals a Haemophilus-predominant subgroupSarah Diver, Matt Richardson, Koirobi Haldar, et al.
The European Respiratory Journal|March 26, 2021
Multi-omics links IL-6 trans-signalling with neutrophil extracellular trap formation and <i>Haemophilus</i> infection in COPDSofia Winslow, Lina Odqvist, Sarah Diver, et al.
The Journal of Allergy and Clinical Immunology|May 1, 2018
Biological exacerbation clusters demonstrate asthma and chronic obstructive pulmonary disease overlap with distinct mediator and microbiome profilesMichael A Ghebre, Pee Hwee Pang, Sarah Diver, et al.
The European Respiratory Journal|August 31, 2019
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questionsArnaud Bourdin, Leif Bjermer, Christopher Brightling, et al.
Pageof 3